We will add to this key list over time and would welcome suggestions or additions. Please send these to: firstname.lastname@example.org
Books, reports, etc
This publication presents a synthesis of studies on drug regulation carried out in ten countries: Australia, Cuba, Cyprus, Estonia, Malaysia, the Netherlands, Tunisia, Uganda, Venezuela, and Zimbabwe in 1998-1999. It gives an overview of the development of drug regulation in these countries as well as the resources available and the strategies applied in drug regulation implementation at the time the studies were conducted. An analysis of the strengths and weaknesses in drug regulation in these countries is also provided
This document brings together the outcomes of six surveys into medicine prices - for Ghana, Kenya, Mali, Tanzania, Chad and Uganda - and one for the East African Community (Kenya, Uganda and Tanzania) . The reports for Mali and Chad are written in French and the others in English
This study aims to identify current opioid prescribing services and regulatory bodies within 12 African PEPFAR (Presidents Emergency Plan for AIDS Relief ) countries, and to examine the barriers to, and appraise the potential for, expansion in the number of opioid providers, for people with HIV and AIDS according to the World Health Organization pain ladder. It concludes that while there are common issues raised by services and International Narcotics Control Board competent authorities, it is clear that these key stakeholders have concerns regarding the potential roll-out of opioids
This study describes and analyses civil society in Uganda, including how civic actors relate to each other and to government and its policies at central and local level . The study also aims to identify important actual issues, actors and roles as well as the main challenges for civil society and their implications for Norway’s future relations with Uganda
This report assesses the quality of antiretroviral medicines obtained at accredited public and private sector antiretroviral procurement and treatment sites in selected African countries. The aim is to help with the development of appropriate quality assurance strategies for antiretrovirals
This research report considers the challenges faced by a local pharmaceutical firm - Quality Chemicals - in Uganda, which was started up as a 'solution' to reducing the high cost of medicines and improving access to medicines. "...many burdens and barriers to access continue to seriously hinder the success of such enterprises. Indirect government subsidies to exporters selling into African markets, and pressure by donors and lobbyists on innovator producers to offer developing countries subsidised prices, actually undermine the competitiveness and viability of these nascent firms. Furthermore, the focus on drug pricing and local production can actually undermine the overall aim to increase access to medicines"
The Uganda national drug policy has been created to help ..."contribute to the attainment of a good standard of health by the population of Uganda, through ensuring the availability, accessibility and affordability of essential drugs of appropriate quality, safety and efficacy and by promoting their rational use"
This paper examines the community’s perspectives and perceptions on quality of health care delivery in two Uganda districts. The paper addresses community concerns on service quality. It focuses on the poor because they are a vulnerable group and often bear a huge burden of disease
The local manufacturing of pharmaceuticals is a hotly contested issue in many countries. It runs to the heart of key concerns such as quality, availability, and price of medicines. Some of the arguments of the local manufacturers are set out in this article by one of the co-chairs of the Medicines Transparency Alliance Uganda Council and Chairman of the Uganda Pharmaceutical Manufacturer's Association (UPMA)